$8.99 5%
AURA Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Aura Biosciences

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer.

Aura Biosciences
Price $8.99
Target Price Sign up
Volume 139,300
Market Cap $424M
Year Range $6.81 - $9.24
Dividend Yield 0%
Revenue per Employee $129,643
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '242.7M5.3M-2.6M-20M-22M-0.399
Q4 '232.4M4.5M-2.1M-22M-24M-0.560
Q3 '232M5.1M-3.1M-19M-19M-0.480
Q2 '232M5.2M-3.1M-18M-20M-0.480
Q1 '232M5M-3M-17M-19M-0.460

Insider Transactions View All

Feder Julie B filed to sell 62,991 shares at $7.6.
January 24 '24
De Los Pinos Elisabet filed to sell 161,438 shares at $7.6.
January 24 '24
Matrix Capital Management Company, LP filed to buy 6,922,870 shares at $9.
November 9 '23
Johnson David Michael filed to buy 135,667 shares at $7.3.
November 9 '23
Johnson David Michael filed to buy 75,000 shares at $7.3.
November 9 '23

What is the Market Cap of Aura Biosciences?

The Market Cap of Aura Biosciences is $424M.

How Many People Work at Aura Biosciences?

As of our latest update, Aura Biosciences employed approximately 70 people worldwide. However, it's important to note that Aura Biosciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Aura Biosciences' revenue per employee?

$129,643. To calculate Aura Biosciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Aura Biosciences?

Currently, the price of one share of Aura Biosciences stock is $8.99.

How can I analyze the AURA stock price chart for investment decisions?

The AURA stock price chart above provides a comprehensive visual representation of Aura Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aura Biosciences shares. Our platform offers an up-to-date AURA stock price chart, along with technical data analysis and alternative data insights.

Does AURA offer dividends to its shareholders?

As of our latest update, Aura Biosciences (AURA) does not offer dividends to its shareholders. Investors interested in Aura Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Aura Biosciences?

Some of the similar stocks of Aura Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.